DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Guanfacine (Guanfacine Hydrochloride) - Current Clinical Trials

 
 



Guanfacine Related Clinical Trials

PK/PD Comparison of Guanfacine ER and IR [Active, not recruiting]

Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65). [Completed]

Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence [Completed]

Does Guanfacine Attenuate Stress-Induced Drinking? [Recruiting]

Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH) [Recruiting]

Guanfacine Clinical Trial for Smoking Cessation [Recruiting]

Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance [Recruiting]

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder [Completed]

Guanfacine Immediate-release Electrocardiogram Results (QTc) Study [Completed]

The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects [Completed]

Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia [Terminated]

Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD) [Completed]

Guanfacine in Children With Tic Disorders [Active, not recruiting]

Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD [Recruiting]

CRT-Guanfacine for SPD [Recruiting]

Efficacy of Intuniv Extended Release as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD [Recruiting]

Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia [Active, not recruiting]

Guanfacine for the Treatment of Spatial Neglect and Impaired Vigilance [Completed]

Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder [Recruiting]

Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe [Active, not recruiting]

Guanfacine to Treat Borderline Personality Disorder [Recruiting]

Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder [Recruiting]

Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl [Completed]

Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study) [Completed]

Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine [Completed]

Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse [Recruiting]

An fMRI Study of Non-Stimulant Treatment of ADHD [Recruiting]

Pharmacology of Cognition in Schizotypal Personality Disorder [Recruiting]

Inuniv and Working Memory [Completed]

Modeling Stress-precipitated Smoking Behavior for Medication Development [Recruiting]

SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms [Completed]

Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) [Completed]

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) [Completed]

Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD) [Completed]

DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension [Terminated]

DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension [Completed]

Stress and Medication Effects on Cocaine Cue Reactivity [Completed]

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder [Completed]

A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers [Completed]

Interventions for Children With Attention and Reading Disorders [Active, not recruiting]

Treatment of Supine Hypertension in Autonomic Failure [Recruiting]

Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17 [Completed]

A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy Volunteers [Completed]

Efficacy and Safety of SPD503 in Combination With Psychostimulants [Completed]

SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP) [Completed]

Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 [Completed]

Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD) [Completed]

Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 [Completed]

Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders [Completed]

The Role of Norepinephrine in Emotional Processing [Completed]

Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts [Completed]

N-acetylcysteine (NAC) for Children With Tourette Syndrome [Completed]

Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017